Edition:
United Kingdom

People: Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

0.53USD
19 Jul 2019
Change (% chg)

$-0.02 (-3.90%)
Prev Close
$0.55
Open
$0.53
Day's High
$0.55
Day's Low
$0.52
Volume
14,826
Avg. Vol
118,175
52-wk High
$1.87
52-wk Low
$0.51

McBarron, Paul 

Mr. Paul McBarron serves as Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Secretary, Director of Cyclacel Pharmaceuticals Inc. Mr. McBarron has served as a director of the Company since March 2006. Mr. McBarron joined Cyclacel in January 2002 and has over 24 years of experience with pharmaceutical and biotechnology companies. He has served as a financial executive at Sterling Drug, Sanofi-Winthrop and SmithKline Beecham and, from 1996 to 2001, as a senior member of the finance team at Shire Pharmaceuticals plc, where he held the positions of Director of Corporate Finance and Group Financial Controller. He joined Shire when it was an emerging public company. He qualified as a chartered accountant with Ernst & Young and serves on the Scottish Lifesciences Association Board.

Basic Compensation

Total Annual Compensation, USD 431,032
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 166,215
Fiscal Year Total, USD 597,247

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --